Amphastar Pharmaceuticals, Inc. (AMPH) vs Avalyn Pharma Inc. Common Stock (AVLN)
A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and Avalyn Pharma Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMPH
Amphastar Pharmaceuticals, Inc.
$25.37HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
AVLN
Avalyn Pharma Inc. Common Stock
$27.03HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AMPH vs AVLN
growth of $100 · dividends reinvested · last 1yAMPH +17.2% (+17.2%/yr)AVLN -8.3% (-8.3%/yr)AMPH compounded faster over this window
AMPH AVLN
AMPH vs AVLN: by the numbers
- •AVLN is the larger company ($1.20B vs $1.12B market cap).
- •AMPH is profitable (10.76% net margin) while AVLN runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AMPH | AVLN |
|---|---|---|
| P/E ratio | 15.01 | N/A |
| Forward P/E | 8.54 | N/A |
| PEG ratio | 0.11 | N/A |
| P/S ratio | 1.53 | N/A |
| P/B ratio | 1.46 | 3.01 |
| EV / EBITDA | 8.82 | N/A |
| FCF yield | 13.67% | N/A |
Profitability
| Metric | AMPH | AVLN |
|---|---|---|
| Gross margin | 47.68% | 0.00% |
| Operating margin | 15.66% | 0.00% |
| Net margin | 10.76% | 0.00% |
| ROE | 10.23% | N/A |
| ROIC | 5.93% | -67.73% |
Growth (annualized)
| Metric | AMPH | AVLN |
|---|---|---|
| Revenue CAGR (5Y) | 13.71% | N/A |
| EPS CAGR (5Y) | 134.23% | N/A |
| FCF CAGR (5Y) | 23.90% | N/A |
| Total return CAGR (5Y) | 6.13% | N/A |
Frequently asked
- Is AMPH or AVLN more profitable?
- AMPH runs the higher net margin — AMPH at 10.76% versus AVLN at 0.00%.
Go deeper
Dig into the metrics
Amphastar Pharmaceuticals P/E ratioAmphastar Pharmaceuticals ROEAvalyn Pharma Inc. Common Stock ROEAmphastar Pharmaceuticals operating marginAvalyn Pharma Inc. Common Stock operating marginAmphastar Pharmaceuticals revenue growthAvalyn Pharma Inc. Common Stock revenue growthAmphastar Pharmaceuticals free cash flowAvalyn Pharma Inc. Common Stock free cash flow
Amphastar Pharmaceuticals & Avalyn Pharma Inc. Common Stock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.